APA

Allavena P., Peccatori F., Maggioni D., Erroi A., Sironi M., Colombo N., Lissoni A., Galazka A., Meiers W. & Mangioni C. (19901207). Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. : Cancer research.

Chicago

Allavena P, Peccatori F, Maggioni D, Erroi A, Sironi M, Colombo N, Lissoni A, Galazka A, Meiers W and Mangioni C. 19901207. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. : Cancer research.

Harvard

Allavena P., Peccatori F., Maggioni D., Erroi A., Sironi M., Colombo N., Lissoni A., Galazka A., Meiers W. and Mangioni C. (19901207). Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. : Cancer research.

MLA

Allavena P, Peccatori F, Maggioni D, Erroi A, Sironi M, Colombo N, Lissoni A, Galazka A, Meiers W and Mangioni C. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. : Cancer research. 19901207.